Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019

SELL
$14.16 - $25.34 $2.83 Million - $5.07 Million
-200,000 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$27.0 - $30.25 $5.4 Million - $6.05 Million
200,000 New
200,000 $5.43 Million

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $159M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Crosslink Capital Inc Portfolio

Follow Crosslink Capital Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crosslink Capital Inc, based on Form 13F filings with the SEC.

News

Stay updated on Crosslink Capital Inc with notifications on news.